Zobrazeno 1 - 10
of 657
pro vyhledávání: '"Eileen M O'Reilly"'
Autor:
Padmanee Sharma, Asim Amin, Dung T Le, Michael A Morse, Marina Tschaika, Matthew H Taylor, Margaret Callahan, Katriina J Peltola, Frederic J Kaye, Eileen M O'Reilly, Stephanie Meadows Shropshire, Shaun O'Brien
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 2 (2024)
Background Pancreatic cancer is one of the deadliest cancer types and represents a major unmet medical need. CheckMate 032 investigated safety and efficacy of nivolumab monotherapy and nivolumab plus ipilimumab with/without cobimetinib in advanced/me
Externí odkaz:
https://doaj.org/article/45a8cb7600f34aa197804f7caa0fc19c
Autor:
Robert H Vonderheide, Andrew H Ko, Danny Khalil, Oliver Rosen, Robert A Wolff, James Francis, Samantha Bucktrout, Christopher R Cabanski, Silvia Boffo, Zev A Wainberg, Samik Upadhaya, Eileen M O’Reilly, Mark H O’Hara, George Fisher, Jamie Arnott, Ana Rosa Saez-Ibanez, Jay Campbell, Ute Dugan, Jill O’Donnell-Tormey
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/b601525223344c068784d6ee00423943
Autor:
James Harding, Allison Richards, Dae Won Kim, Wungki Park, Kevin Soares, Danny Khalil, Olca Basturk, Mark Donoghue, William Jarnagin, Darren Cowzer, Ghassan Abou-Alfa, Fergus Keane, Hulya Sahin Ozkan, Vasilisa Rudneva, Bruno A Costa, Zeyneb Tarcan, Eileen M O’Reilly
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/20f72e96366d4b2f86a1fdb822d30632
Autor:
Jayasree Chakraborty, Liana Langdon-Embry, Kristen M Cunanan, Joanna G Escalon, Peter J Allen, Maeve A Lowery, Eileen M O'Reilly, Mithat Gönen, Richard G Do, Amber L Simpson
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0188022 (2017)
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers in the United States with a five-year survival rate of 7.2% for all stages. Although surgical resection is the only curative treatment, currently we are unable to differentiate
Externí odkaz:
https://doaj.org/article/65392512829b4c99a410fcc1b209e5c4
Autor:
Ghassan K. Abou-Alfa, Tim Meyer, Richard Kinh Gian Do, Sarina A. Piha-Paul, Joseph S. Light, Scott Sherrin, Amin Yaqubie, Alison Clemens O’Neill, James J. Harding, Raed Al-Rajabi, Crystal S. Denlinger, Pablo Cano, Albert S. Cornelius, Eileen M. O'Reilly, Daniel DiPrimeo, Lisa D. Eli, John D. Gordan, David B. Solit
Publikováno v:
Liver Cancer (2024)
Introduction: Fibrolamellar carcinoma (FLC) displays upregulation of several oncogenes, including HER2, and multiple immune-suppressive mechanisms. We investigated the efficacy and safety of the pan-HER tyrosine kinase inhibitor neratinib as monother
Externí odkaz:
https://doaj.org/article/060277f2d7054affa161c9c60698ca95
Autor:
Jordan M Winter, Laura H Tang, David S Klimstra, Murray F Brennan, Jonathan R Brody, Flavio G Rocha, Xiaoyu Jia, Li-Xuan Qin, Michael I D'Angelica, Ronald P DeMatteo, Yuman Fong, William R Jarnagin, Eileen M O'Reilly, Peter J Allen
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40157 (2012)
One-fifth of patients with seemingly 'curable' pancreatic ductal adenocarcinoma (PDA) experience an early recurrence and death, receiving no definable benefit from a major operation. Some patients with advanced stage tumors are deemed 'unresectable'
Externí odkaz:
https://doaj.org/article/e16504354f8e464f87e856fdaa911bdc
Autor:
Brett L. Ecker, Alice J. Tao, Quisette P. Janssen, Henry S. Walch, Colin M. Court, Vinod P. Balachandran, Christopher H. Crane, Michael I. D'Angelica, Jeffrey A. Drebin, T. Peter Kingham, Kevin C. Soares, Christine A. Iacobuzio-Donahue, Efsevia Vakiani, Mithat Gonen, Eileen M. O'Reilly, Anna M. Varghese, William R. Jarnagin, Alice C. Wei
Publikováno v:
Clinical Cancer Research : an official journal of the American Association for Cancer Research, 29(7), 1368-1374. American Association for Cancer Research Inc.
Purpose: There is increasing use of neoadjuvant chemotherapy in the management of localized pancreatic ductal adenocarcinoma (PDAC), yet there are few validated biomarkers to guide therapy selection. We aimed to determine whether somatic genomic biom
Publikováno v:
Cancer Medicine. 12:9496-9505
Autor:
Justin C. Brown, Chao Ma, Qian Shi, Charles S. Fuchs, Jeffrey Meyer, Donna Niedzwiecki, Tyler Zemla, Felix Couture, Philip Kuebler, Pankaj Kumar, DeQuincy Lewis, Benjamin Tan, Smitha Krishnamurthi, Eileen M. O'Reilly, Anthony F. Shields, Jeffrey A. Meyerhardt
Publikováno v:
Journal of Clinical Oncology. 41:243-254
PURPOSE To determine the specific types, durations, and intensities of recreational physical activity associated with the greatest improvements in disease-free survival (DFS) of patients with colon cancer. METHODS We conducted a prospective cohort st
Autor:
Brett L, Ecker, Colin M, Court, Quisette P, Janssen, Alice J, Tao, Michael I, D'Angelica, Jeffrey A, Drebin, Mithat, Gonen, Eileen M, O'Reilly, William R, Jarnagin, Alice C, Wei, Efsevia, Vakiani
Publikováno v:
Journal of the American College of Surgeons. 235(2)
There is increased use of neoadjuvant fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) in the management of localized pancreatic ductal adenocarcinoma (PDAC), yet there are few validated biomarkers of treatment response.Consecutive